Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,659 | -14,032 | -8,294 | -6,788 | -35,152 |
| Depreciation Amortization | 1,580 | 1,177 | 773 | 380 | 1,244 |
| Accounts receivable | -4,423 | -3,045 | -2,933 | -694 | -2,479 |
| Accounts payable and accrued liabilities | -3,495 | -5,742 | -4,053 | -393 | 2,688 |
| Other Working Capital | -13,677 | -15,811 | -14,160 | -4,984 | 1,359 |
| Other Operating Activity | 12,475 | 11,603 | 8,803 | 1,821 | 6,005 |
| Operating Cash Flow | $-28,199 | $-25,851 | $-19,863 | $-10,658 | $-26,333 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,000 | 6,000 | 6,000 | 3,000 | 24,000 |
| PPE Investments | -5,643 | -5,013 | -4,091 | -1,890 | -4,663 |
| Purchase Of Investment | -15,038 | -15,038 | -15,038 | N/A | N/A |
| Purchase Sale Intangibles | -1,043 | -1,008 | -960 | -928 | -990 |
| Other Investing Activity | -1,043 | -1,008 | -960 | -928 | -990 |
| Investing Cash Flow | $-15,724 | $-15,059 | $-14,089 | $183 | $18,347 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 42,882 | 42,851 | 43,115 | N/A | 3,105 |
| Other Financing Activity | -88 | -88 | -68 | -11 | -154 |
| Financing Cash Flow | $42,794 | $42,763 | $43,047 | $-11 | $2,951 |
| Exchange Rate Effect | -1 | -1 | 1 | 1 | -3 |
| Beginning Cash Position | 34,029 | 34,029 | 34,029 | 34,029 | 39,067 |
| End Cash Position | 32,899 | 35,881 | 43,125 | 23,543 | 34,029 |
| Net Cash Flow | $-1,130 | $1,852 | $9,096 | $-10,486 | $-5,038 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,199 | -25,851 | -19,863 | -10,658 | -26,333 |
| Capital Expenditure | -5,643 | -5,013 | -4,091 | -1,890 | -4,663 |
| Free Cash Flow | -33,842 | -30,864 | -23,954 | -12,548 | -30,997 |